BGLC
BioNexus Gene Lab Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
BioNexus Gene Lab Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No other changes.
No other changes.
Annual filing, covered
10-K parsed · Apr 14 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Apr 14 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
N/A
N/A
No thesis.
Largest filed tie
0
filed ties
—
Same SIC code · 6
Same SEC industry code: Quest Diagnostics Inc, Labcorp Holdings Inc., Veracyte, Inc. and 3 more; no measured co-movers for BioNexus Gene Lab Corp.
Same SIC code · 6
Same SEC industry code: Quest Diagnostics Inc, Labcorp Holdings Inc., Veracyte, Inc. and 3 more; no measured co-movers for BioNexus Gene Lab Corp.
—
BioNexus Gene Lab Corp
0.95
| Manager | Value | % base | |
|---|---|---|---|
| HRT Financial | $28,000 | 99.29% | new |
| UBS | $197 | 0.70% | −56.28% |
| Caitong International | $2 | 0.01% | new |
| Manager | Value | % base | |
|---|---|---|---|
| HRT Financial | $28,000 | 99.29% | new |
| UBS | $197 | 0.70% | −56.28% |
| Caitong International | $2 | 0.01% | new |
—
Expected move
No implied move.